Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III

NCT02973243 is registered in ClinicalTrials.gov with Philips Healthcare as lead sponsor.

NCT NCT02973243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
Lead sponsor
Philips Healthcare
Phase
Observational
Overall status
Completed
Start date
October 5, 2016
Completion date
February 28, 2017
Enrollment
446 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, myocardial infarction, renal failure, respiration failure, severe sepsis